to 12 years of age, 3 the trend in practice is to prescribe repeated maternal courses of corticosteroid in high-risk pregnancy where the risk of preterm birth persists or recurs. 4 No randomised data of outcomes in human pregnancy exist to support the safety of repeated administration of corticosteroid.
Here we have investigated the effect of repeated corticosteroid therapy on the development of the central nervous system by examining retinal maturation. The retina is of particular clinical interest for several reasons. The mammalian retina is produced in two major phases of cell generation. The 'homochrony' hypothesis predicts that in humans the second phase of retinal cell generation occurs from 15 to 24 weeks of gestation. s A survey of clinical practice suggests that corticosteroids are prescribed under 24 weeks gestation, 4 thus coinciding with the latter part of the second phase of retinal cell generation. During this phase, the retinae also undergo marked lateral expansion, particularly in the periphery, through the differential addition of second-phase cells to peripheral rather than central retina. 6 The retina is therefore potentially directly vulnerable to corticosteroid therapy, which has known antimitotic effects on DNA, RNA and protein synthesis in the nervous system. 7 , 8 Finally, although there is general agreement that low birthweight preterm infants are at risk for impaired motor development, recent evidence suggests they are also specifically vulnerable to impaired visual development. 9 -11 We predicted that the weekly administration of corticosteroids could affect retinal maturation. Calculations derived utilising 'homochrony' hypothesis assumptions S , 12 , 1 3 revealed that the second phase of ovine retinal cell generation would be taking place from day 71 to 115 of gestation. To examine the effects of single and repeated exposures to corticosteroid in a clinically relevant animal model, we examined retinal maturation in sheep during the latter part of this gestational period. Retinal maturation was quantified using eye growth as a measure of lateral expansion of the retinae, and retinal thickness as a measure of the maturation of cells added in the second phase of neurogenesis.
Methods
Institutional animal ethics committee approval was obtained and animal maintenance and care conformed to the principles outlined by the NH&MRC (Australia). Findings on birthweight have been reported previously. 1 4 Date-mate ewes were randomised into one of three treatment groups: control (n = 12), single (n =12) and repeated corticosteroid (n = 12) treatments. Ewes received an injection of betamethasone (Celestone Chrondose 0.5 mg/kg, i.m.) on day 104 of gestation in the single corticosteroid group, and on days 104, 111, 118 and 124 in the repeated corticosteroid group. Injections of sterile normal saline of equivalent volume were given on days 111, 118 and 124 in the single corticosteroid group, and on all four days in the control group. All animals had previously received an intramuscular injection of medroxyprogesterone acetate (Depo-Provera, Upjohn, 150 mg) on day 100 to minimise the risk of pre term birth.
On day 125 or 145, ewes were premedicated with ketamine (100 mg/ml, 12 ml i.m.; Parke Davis, Ireland) and lambs delivered by caesarean section after spinal anaesthesia with lignocaine (Xylocaine 1%, 4 ml intraspinal, Astra, Australia). Newborns were killed (ketamine 5 ml i.v.; Parke Davis, Ireland: Lethobarb 2 ml i.v.) and then transcardially perfused with heparinised saline followed by modified Karnovsky's fixative in cacodylate buffer (0.1 M, 300 mosmol, pH 7.4). Skulls were opened from a ventral approach and dissection of
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Control the eyes completed with the aid of an operating microscope. The maximum diameter of each eye was recorded in two axes (nasal-temporal, ventral-dorsal) using Vernier calipers, with measurements rounded to the nearest millimetre.
The cornea, iris and lens were removed with iridectomy scissors and the vitreous removed with cotton buds. In all ungulates, a streak of high cell density extends along a straight horizontal line, dorsal to the optic disc. IS The visual streak was clearly defined by a yellow band that widened at the area centralis, an area of high retinal ganglion cell density immediately temporal to the optic disc. Two millimetre square segments of retina from the area centralis and ventral periphery were removed, representing an area of high and low ganglion cell density respectively.
Tissue was postfixed for 2 h in osmium tetroxide, dehydrated in graded ethanols and propylene oxide, and embedded in Epon-Araldite. Tissue blocks were labelled with a code to mask the operator who would perform the subsequent measurements. Transverse semi-thin sections cut with a microtome and stained with toluidine blue were used to estimate the total retinal width, and that of its respective cellular and plexiform layers, which were clearly defined in the light microscope (Figs. 1, 2). Data were collected using frame-grabbed images of the semi thin sections and analysed with an Optimus image analysis system, calibrated with a standard graticule. Measurements from each retina were repeated on three separate sections to obtain a mean for each animal.
A mixed model analysis of variance was applied to generate p values. Multivariate ANOV As were applied to control for any effect of maternal weight, birthweight,
Single
Repeated Fig. 1 . The effect on retinal thickness of single and repeated corticosteroid therapy compared with control in the ventral periphery and area centralis following delivery at 125 days. Retinae from animals exposed to repeated. but not single. corticosteroid treatments were significantly thinner than control at both the ventral periphery and area centralis (p < 0.0001).
Control Single Repeated
Ventral periphery Area Centralis The effect on retinal thickness of single and repeated corticosteroid therapy compared with control in the ventral periphery and area centralis following delivery at 145 days. Retinae from animals exposed to repeated. but not single, corticosteroid treatments were significantly thicker than control in the ventral periphery (p < O.OOOl).
gender or laterality upon outcome measures. A p value of 0.03 was considered significant because of the multiple estimations. Results are presented as adjusted mean and 95% confidence interval of the difference between the means.
Results
In control animals, eye diameter increased significantly between 125 and 145 days (39% increase, p = 0.02; Fig. 3 ).
There was a concurrent thinning of the retinae which was more marked at the ventral periphery (15% reduction, p = 0.0001) than at the area centralis (9% reduction, p = 0.0001). Individual retinal layers showed variation in their thinning. In the ventral periphery, the most marked thinning was found in the ganglion cell layer (34% reduction, p = 0.0001), but in the area centralis the photoreceptor outer segments layer was most affected (46% reduction, p = 0.0001; Tables 1, 2) .
Eye diameter was similar in the control and single corticosteroid groups at both 125 and 145 days (p > 0.81; Fig. 3) . Similarly, no significant differences were detected in the values of retinal thickness between the control and single corticosteroid treatment at either gestational age (p> 0.09; Tables 1, 2 , Figs. 1, 2 ).
In contrast, repeated corticosteroid therapy significantly altered patterns of eye growth. At 125 days, eye diameters were not significantly smaller compared with controls (p= 0.45), but at 145 days values were Significantly reduced (p = 0.03; Fig. 3 ). Repeated corticosteroid treatment thus resulted in a relative failure of the eye to increase in diameter between days 125 and 145 of gestation, even though no further corticosteroid was administered during this period.
Despite eye size being similar to controls at 125 days following repeated corticosteroid therapy, the retinae were significantly thinner in both the ventral periphery Mean eye diameter in the three treatment groups at 125 and 145 days gestational age. Eyes from animals exposed to repeated corticosteroid treatments failed to increase significantly in diameter between 125 and 145 days, despite no further drug being administered in this period. Thus, at 145 days, eye size was significantly reduced following repeated corticosteroid treatment compared with saline control (p = OJJ3). Between 125 and 145 days, a period during which control eyes increased in size and retinae significantly thinned, the pattern of development of the eyes exposed 
Discussion
The findings of the present study support our knowledge of normal mammalian retinal development 5 . 6 . 12 . 1 3 . 15 -1 8 and suggest that repeated prenatal exposure to maternally administered corticosteroids may delay this development. The absence of significant differences between retinae of control and single corticosteroid exposed newborns also reinforces the safety findings of a single course of corticosteroid therapy derived from prospective clinical trials in humans ?
We predicted that in sheep, between days 71 and 115 days of gestation, the retinae would thicken as second phase retinal cells were generated. By 125 days, we anticipated the second phase of retinal cell generation would be complete; in accord with this assumption, mitotic figures were not seen in the retinae at E125. However, overall retinal growth would still be in progress in terms of the generation of extracellular matrix, cellular processes, synapse formation and dendritic elaboration. The growth would largely be in the plexiform, rather than the cellular, layers of the retinae and allows for continuing lateral expansion of the retinae, particularly in the periphery. We observed such a pattern, with the eye size of control animals significantly increasing between day 125 and 145, with concomitant thinning of some retinal cellular layers, predominantly in the periphery where lateral expansion is most marked. Repeated corticosteroid therapy disrupted these patterns of retinal development, a disruption that persisted at term, 20 days after the cessation of treatment. At 125 days, immediately after the completion of the second phase of retinal cell generation, retinae in the repeated corticosteroid treatment group were significantly thinner than controls. The finding suggests that repeated corticosteroid treatment may have delayed retinal maturation by extending the duration of the second phase of retinal cell generation. Consequent delays would therefore take place in events such as the Between day 125 and 145 of gestation, a phase of lateral retinal expansion, when control eyes grew in size and retinae thinned, the diameters of the eyes in the repeated corticosteroid treatment group failed to increase significantly and achieved an increase in retinal width only equivalent to that achieved in controls 20 days earlier. Thus, the delays in retinal development appear to correlate with the 20 day time period during which repeated corticosteroid therapy was administered, suggesting a temporary arrest of retinal development occurred at this stage. Corticosteroids are known to affect DNA, RNA and protein synthesis in the central nervous system ? ' S The outcome of their action upon the fetus seems to be dependent upon the cellular events that occur during the period of administraticin. 19 -22 For example, biochemical analysis has demonstrated that myelination in the ovine central nervous system is in progress between 104 and 125 days? 3 The effect of corticosteroid administration
